The gene expressions of VEGFA, CXCL12, and TGF-β1 regulating hematopoiesis were significantly downregulated in the IO MDS group compared with those in the NIO MDS and control groups (p < 0.05) (Figure 1(e) A–C). The gene discussed is TGFB1; the disease is myelodysplastic syndrome.